News

Element Announces Expanded Customer Base, New Products, and Unprecedented Capabilities on a Benchtop Sequencer

Element has exceeded 160 orders, generating more than $25 million in revenue in 2023 Element announces roadmap for suite of new products in 2024 SAN DIEGO, Jan. 8, 2024 /PRNewswire/ — Element Biosciences, Inc., developer […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

LA JOLLA, Calif.–(BUSINESS WIRE)—- $LBPH #Epilepsy–Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks
News

Knowtex and 4D EMR Announce Groundbreaking Partnership to Revolutionize Clinical Workflow with Specialty-Specific Voice and Generative AI EMR System

Knowtex and 4D EMR, two innovative leaders in medical technology, are thrilled to announce a pioneering partnership that will introduce the first specialty-specific voice and generative AI electronic medical records (EMR) workflow. SAN DIEGO, Jan. […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Washington State HCA Removes Prior Authorization for Hormone-Free “In the Moment” Contraceptive PHEXXI Ahead of Huskies vs. Wolverines Championship Game

— Removal of Prior Authorization Upgrades Phexxi Coverage for Nearly 1.8 Million Washington Lives Across All Medicaid Plans — — Fans Encouraged to Plan for Victory, Prevent Unintended Pregnancy — SAN DIEGO, Jan. 8, 2024 […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Ionis poised for continued momentum in 2024 with product launches and key advances in robust pipeline of investigational medicines for serious diseases

– Numerous value-driving commercial, regulatory and pipeline milestones anticipated – CARLSBAD, Calif., Jan. 8, 2024 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced highlights from the Company’s 2023 achievements and previewed a number of […]

No Picture
News

Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain

SAN DIEGO, Jan. 7, 2024 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that it has entered into a five-year distributor partnership with CrossLink Life Sciences, LLC to expand the […]

News

Roche leads pre-JPM deal spree; Roger Perlmutter’s new pharma force; Inside Sage’s big triumph and failure; Late Friday IPO filings; All new drugs in 2023; and more

Welcome to the first issue of Endpoints Weekly in 2024! The year is starting strong, and there will be no shortage of topics for my colleagues to discuss with JP Morgan conference-goers. Say hi if […]


ADVERTISEMENT — Advertise With Biotech Networks
News

PassPort Technologies Commences Collaborative Research with Arcturus Therapeutics to Evaluate Transdermal mRNA delivery systems

Arcturus’s mRNA medicines and vaccines and lipid-mediated drug delivery systems in combination with PassPort’s innovative transdermal drug delivery system. SAN DIEGO, Jan. 5, 2024 /PRNewswire/ — PassPort Technologies, Inc. (PPTI), led by President and CEO […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

Thermo Fisher Scientific Launches PangenomiX Array to Support Population-Scale Disease Studies and Pharmacogenomics Research

CARLSBAD, Calif.–(BUSINESS WIRE)–Earlier this year, scientists unveiled the first draft of the pangenome, based on full genetic blueprints from 47 people around the world to create a more diverse representation of the human genome1. To […]